XML 16 R3.htm IDEA: XBRL DOCUMENT v3.25.1
Award Timing Disclosure
12 Months Ended
Dec. 31, 2024
Apr. 09, 2024
USD ($)
shares
$ / shares
Feb. 29, 2024
USD ($)
shares
$ / shares
Award Timing Disclosures [Line Items]      
Award Timing MNPI Disclosure
POLICIES AND PRACTICES RELATED TO THE GRANT OF CERTAIN EQUITY AWARDS CLOSE IN TIME TO THE RELEASE OF MATERIAL NONPUBLIC INFORMATION
From time to time, the Company grants stock options to its employees, including the named executive officers. Historically, the Company has granted new-hire option awards on or soon after a new hire’s employment start date and annual refresh employee option grants in February each year, which refresh grants are typically approved at a meeting of the Compensation Committee occurring in February. The Company’s typical practice is to grant refresh employee stock options on the last business day of the month of February. Also, non-employee directors receive automatic grants of initial and annual stock option awards, at the time of a director’s initial appointment or election to the board and at the time of each annual meeting of the Company’s stockholders, respectively, pursuant to the Non-Employee Director Compensation Policy, as further described under the heading, “Compensation For Directors”. The Company does not otherwise maintain any written policies on the timing of awards of stock options, stock appreciation rights, or similar instruments with option-like features. Because stock option grant dates are generally determined by extrinsic events such as employee or director start dates or annual meeting dates or, in the case of annual refresh stock options, typically occur on the last business day of February, the Compensation Committee generally does not take material nonpublic information (“MNPI”) into account when determining the timing of awards and it does not seek to time the award of stock options in relation to the Company’s public disclosure of MNPI.
   
Award Timing Method From time to time, the Company grants stock options to its employees, including the named executive officers. Historically, the Company has granted new-hire option awards on or soon after a new hire’s employment start date and annual refresh employee option grants in February each year, which refresh grants are typically approved at a meeting of the Compensation Committee occurring in February. The Company’s typical practice is to grant refresh employee stock options on the last business day of the month of February. Also, non-employee directors receive automatic grants of initial and annual stock option awards, at the time of a director’s initial appointment or election to the board and at the time of each annual meeting of the Company’s stockholders, respectively, pursuant to the Non-Employee Director Compensation Policy, as further described under the heading, “Compensation For Directors”.    
Award Timing Predetermined true    
Award Timing MNPI Considered false    
Award Timing, How MNPI Considered The Company does not otherwise maintain any written policies on the timing of awards of stock options, stock appreciation rights, or similar instruments with option-like features. Because stock option grant dates are generally determined by extrinsic events such as employee or director start dates or annual meeting dates or, in the case of annual refresh stock options, typically occur on the last business day of February, the Compensation Committee generally does not take material nonpublic information (“MNPI”) into account when determining the timing of awards and it does not seek to time the award of stock options in relation to the Company’s public disclosure of MNPI.    
MNPI Disclosure Timed for Compensation Value false    
Awards Close in Time to MNPI Disclosures, Table
The following table provides information regarding each instance in 2024 when the Company awarded a stock option to a named executive officer in the period beginning four business days before the filing of a periodic report on Form 10-Q or Form 10-K, or the filing or furnishing of a current report on Form 8-K, and ending one business day after the filing or furnishing of such report. Each such instance is included without regard to the Company’s view as to whether the report disclosed MNPI.
Name
(a)
Grant date
(b)
Number of
securities
underlying
the award
(c)
Exercise
price of the
award ($/Sh)
(d)
Grant date
fair value of
the award
(e)
Percentage change in the
closing market price of the
securities underlying the
award between the trading
day ending immediately
prior to the disclosure of
material nonpublic
information and the trading
day beginning immediately
following the disclosure
of material nonpublic
information
(f)
David Hung, M.D.
2/29/24
2,000,000
$1.87
$2,519,960
19.25%
Colleen Sjogren
4/9/24
750,000
$3.23
$1,666,988
3.17%
Gary Hattersley, Ph.D.
2/29/24
500,000
$1.87
$629,990
19.25%
   
David Hung, M.D. [Member]      
Awards Close in Time to MNPI Disclosures      
Name     David Hung, M.D.
Underlying Securities | shares     2,000,000
Exercise Price | $ / shares     $ 1.87
Fair Value as of Grant Date | $     $ 2,519,960
Underlying Security Market Price Change     0.1925
Colleen Sjogren [Member]      
Awards Close in Time to MNPI Disclosures      
Name   Colleen Sjogren  
Underlying Securities | shares   750,000  
Exercise Price | $ / shares   $ 3.23  
Fair Value as of Grant Date | $   $ 1,666,988  
Underlying Security Market Price Change   0.0317  
Gary Hattersley, Ph.D. [Member]      
Awards Close in Time to MNPI Disclosures      
Name     Gary Hattersley, Ph.D.
Underlying Securities | shares     500,000
Exercise Price | $ / shares     $ 1.87
Fair Value as of Grant Date | $     $ 629,990
Underlying Security Market Price Change     0.1925